On May 19, 2021, LEAPS hosted a virtual Design Lab on behalf of MIT Lincoln Labs, DTRA (the Defense Threat Reduction Agency), and its DOMANE (Discovery of Medical countermeasures Against Novel Entities) project. The … Read More
LEAPS Monthly Recap: March 2021
NEW WORKSTREAM Margaux Hall to co-lead Fit-for-Purpose RWE evaluation Margaux Hall, Partner at Ropes and Gray and valued collaborator in the NEWDIGS FoCUS (Financing of Cures in the US) Project, will … Read More
Margaux Hall to co-lead Fit-for-Purpose RWE evaluation
Margaux Hall, Partner at Ropes and Gray and valued collaborator in the NEWDIGS FoCUS (Financing of Cures in the US) Project, will be co-leading a new workstream in LEAPS focused on … Read More
Dr. Hans-Georg Eichler to co-author publication on RWE in personalized medicine access and reimbursement
Dr. Hans-Georg Eichler, will be retiring next month from his current position of Senior Medical Officer of the European Medicines Agency (EMA). After his retirement, he will be co-leading the … Read More
Dr Gigi Hirsch hosts fireside chat at the MIT Sloan Healthcare and Bioinnovations Conference
On February 26, Dr Hirsch hosted a conversation with Bill Sibold, Executive Vice President & Head of Sanofi Genzyme, Sanofi, entitled, “The Value of Downstream Innovation—Improving Patient Access to Groundbreaking … Read More
Scipher Medicine is the latest NEWDIGS collaborator for the LEAPS Project
Patient-centered collaboration for regimen optimization CAMBRIDGE, MA January 28, 2021 – Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s … Read More
Dr Hirsch and Dr Larholt invited to NAS workshop
NEWDIGS Exutive Director Gigi Hirsch and Director of Research Kay Larholt were invited to participate in the National Academies of Science’s Envisioning a Transformed Clinical Trials Enterprise for 2030. This workshop is being … Read More
The NEWDIGS Initiative at MIT welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project
Collaboration to enhance the capacity of disease ecosystems for regimen optimization CAMBRIDGE, MA November 25, 2020 – Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat … Read More
LEAPS Monthly Recap: December 2020
NEW MEMBER NEWDIGS welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project Collaboration to enhance the capacity of disease ecosystems for regimen optimization Cerevel Therapeutics, a company dedicated … Read More
Downstream Innovation: Designing infrastructures and environments for real-world disease-focused learning
The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, production, and use of real-world evidence at the level of disease, not … Read More